Immunogen - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsImmunogen

Immunogen(IMGN)

ImmunoGen, Inc. (Nasdaq: IMGN) is a biotechnology company focused on the development of antibody-drug conjugate (ADC) therapeutics for the treatment of cancer. ImmunoGen was founded in 1981 and is headquartered in Waltham, Massachusetts.

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Elahere	Mirvetuximab soravtansine	2022-11-14		Fallopian tube neoplasms , Ovarian epithelial carcinoma , Peritoneal neoplasms

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Mirvetuximab soravtansine

,

,

,

hereditary breast and ovarian cancer syndrome

,

mullerian mixed tumor

,

,

endometrial neoplasms

,

serous cystadenocarcinoma

,

endometrioid carcinoma

,

,

clear cell adenocarcinoma

,

acinar cell carcinoma

,

ovarian neoplasms

,

fallopian tube neoplasms

,

ovarian epithelial carcinoma

,

peritoneal neoplasms

,

,

ovarian neoplasms

,

serous cystadenocarcinoma

,

fallopian tube neoplasms

,

,

hereditary breast and ovarian cancer syndrome

,

mullerian mixed tumor

Rucaparib camsylate

,

,

ovarian neoplasms

,

serous cystadenocarcinoma

,

fallopian tube neoplasms

,

,

hereditary breast and ovarian cancer syndrome

,

mullerian mixed tumor

,

myeloid leukemia acute

,

,

myeloid leukemia

,

breast neoplasms

,

ovarian neoplasms

,

triple negative breast neoplasms

,

fallopian tube neoplasms

,

male breast neoplasms

healthy volunteers/patients

,

,

,

myeloid leukemia acute

,

,

myeloid leukemia

,

community-acquired infections

,

bacterial pneumonia

,

aids-related complex

,

immunologic deficiency syndromes

,

,

,

central nervous system neoplasms

,

germ cell and embryonal neoplasms

,

liver neoplasms

,

nervous system neoplasms

,

,

non-hodgkin lymphoma

,

,

,

,

multiple myeloma

,

plasma cell neoplasms

,

ovarian neoplasms

,

myeloid leukemia acute

,

hodgkin disease

,

,

,

,

acquired immunodeficiency syndrome

,

non-small-cell lung carcinoma

,

prostatic neoplasms

,

,

urinary bladder neoplasms

,

kidney neoplasms

,

transitional cell carcinoma

,

ureteral neoplasms

,

,

,

communicable diseases

,

b-cell lymphoma marginal zone

,

mantle-cell lymphoma

,

large b-cell lymphoma diffuse

,

b-cell lymphoma

,

burkitt lymphoma

,

,

diabetes mellitus

,

type 1 diabetes mellitus

,

,

breast neoplasms

,

,

myeloid leukemia

,

myelodysplastic syndromes

,

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

lymphoid leukemia

,

bcr-abl positive chronic myelogenous leukemia

,

graft vs host disease

,

esophageal neoplasms

,

neoplasm metastasis

,

hepatocellular carcinoma

,

liver neoplasms

,

healthy volunteers/patients

,

,

multiple myeloma

,

,

squamous cell carcinoma

,

plasma cell neoplasms

,

colorectal neoplasms

,

head and neck neoplasms

,

squamous cell carcinoma of head and neck

,

rectal neoplasms

,

non-hodgkin lymphoma

,

,

synovial sarcoma

,

,

,

sezary syndrome

,

t-cell lymphoma

,

t-cell lymphoma peripheral

,

mycosis fungoides

,

t-cell lymphoma cutaneous

,

urologic neoplasms

,

urogenital neoplasms

,

penile neoplasms

,

male urogenital diseases

,

urogenital diseases

,

,

non-small-cell lung carcinoma

,

,

breast neoplasms

,

,

,

urinary bladder neoplasms

,

triple negative breast neoplasms

,

giant cell arteritis

,

polymyalgia rheumatica

,

ulcerative colitis

,

,

,

ankylosing spondylitis

,

spondylarthritis

,

,

rheumatoid arthritis

,

,

ovarian neoplasms

,

fallopian tube neoplasms

,

ovarian epithelial carcinoma

,

uterine cervical neoplasms

,

,

cardiovascular diseases

,

hyperlipidemias

,

familial combined hyperlipidemia

,

hyperlipoproteinemias

,

,

prostatic neoplasms

,

,

b-cell chronic lymphocytic leukemia

,

lymphoid leukemia

,

renal cell carcinoma

,

,

t-cell lymphoma

,

t-cell lymphoma peripheral

,

breast neoplasms

,

non-hodgkin lymphoma

,

b-cell lymphoma

,

ovarian neoplasms

,

fallopian tube neoplasms

,

ovarian epithelial carcinoma

,

urinary bladder neoplasms

ANETUMAB RAVTANSINE

CANTUZUMAB RAVTANSINE

colorectal neoplasms

,

pancreatic neoplasms

,

stomach neoplasms

LORVOTUZUMAB MERTANSINE

multiple myeloma

,

plasma cell neoplasms

,

ovarian neoplasms

,

merkel cell carcinoma

,

,

small cell lung carcinoma

,

,

hematologic neoplasms

parkinson disease

,

central nervous system diseases

,

,

nervous system diseases

,

movement disorders

,

neurodegenerative diseases

,

,

,

colorectal neoplasms

,

,

non-small-cell lung carcinoma

,

head and neck neoplasms

,

esophageal neoplasms

,

,

NARATUXIMAB EMTANSINE

,

non-hodgkin lymphoma

,

,

b-cell chronic lymphocytic leukemia

,

lymphoid leukemia

Polyglycolic acid

1

2

3

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use